))
Robin Feldman on Drug Patents, Generics, and Drug Wars
Archived series ("Inactive feed" status)
When?
This feed was archived on August 29, 2022 10:29 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 181748916 series 1334123
Content provided by EconTalk - ALl. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by EconTalk - ALl or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Robin Feldman of the University of California Hastings College of Law and author of Drug Wars talks about her book with EconTalk host Russ Roberts. Feldman explores the various ways that pharmaceutical companies try to reduce competition from generic drugs. The conversation includes a discussion of the Hatch-Waxman Act and the sometimes crazy world of patent protection.
820 episodes
Share
